Conclusions
Low-dose CCTA provides excellent sensitivity and negative
predictive value in detecting and excluding significant
CAD in patients with T2DM without known or
suspected CAD. The usefulness of this method as a
screening tool in asymptomatic intermediate risk patients
like in T2DM may be limited by a rather low positive
predictive value.